Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

May 11, 2024 13:29 ET
FIRST NATIONAL CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of First National Corporation - FXNC
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of First National Corporation (“the Company”) (NasdaqCM: FXNC) and Touchstone Bankshares, Inc. (OTCPK: TSBA). Under the terms of the proposed transaction, Touchstone shareholders would receive 0.8122 shares of First National stock for each share of Touchstone stock they own. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders....
May 11, 2024 13:29 ET
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Landos Biopharma, Inc. (NasdaqCM: LABP) to AbbVie Inc. (NYSE: ABBV). Under the terms of the proposed transaction, shareholders of Landos will receive $20.42 in cash, plus one non-tradable contingent value right (with a value of up to $11.14 per share, subject to the achievement of a clinical development milestone) for each share of Landos that they own. KSF is seeking to determine whether this consideration and the process that led to it are ...
May 11, 2024 13:12 ET
CAPITAL BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Capital Bancorp, Inc. - CBNK
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Capital Bancorp, Inc. (NasdaqGS: CBNK) (“the Company”) and Integrated Financial Holdings, Inc. Under the terms of the proposed transaction, Integrated shareholders will receive, subject to certain adjustments, $5.36 in cash and 1.115 shares of Capital common stock for each share of Integrated common stock. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders....
May 11, 2024 13:10 ET
ENDEAVOR GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Endeavor Group Holdings, Inc. - EDR
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Endeavor Group Holdings, Inc. (NYSE: EDR) to Silver Lake. Under the terms of the proposed transaction, shareholders of Endeavor will receive $27.50 in cash for each share of Endeavor that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company....
May 11, 2024 12:47 ET
DOMA HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Doma Holdings, Inc. - DOMA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Doma Holdings, Inc. (NYSE: DOMA) to Title Resources Group. Under the terms of the proposed transaction, shareholders of Doma will receive $6.29 in cash for each share of Doma that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company....
May 11, 2024 09:00 ET
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL‑HF, the first Phase 2 proof-of-concept clinical trial of a phosphodiesterase-9 (PDE9)...
May 10, 2024 21:24 ET
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between December 1, 2023 and April 26, 2024. Altimmune is a clinical stage biopharmaceutical company that focuses on developing treatments for obesity and l...
May 10, 2024 18:55 ET
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759 restricted stock units (RSUs) of the company’s common stock to 14 newly hired non-executive em...
May 10, 2024 18:52 ET
KBRA Assigns Ratings to SILAC Insurance Company and Sterling Investors Life Insurance Company
KBRA assigns BBB insurance financial strength ratings to SILAC Insurance Company ("SILAC") and Sterling Investors Life Insurance Company ("SILIC"). The Outlook for both ratings is Stable....
May 10, 2024 18:34 ET
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (NasdaqCM: ABIO) and Oruka Therapeutics. Upon closing of the proposed transaction, ARCA shareholders are expected to own approximately 2.38% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, and whether the merger is fair to ARCA shareholders....
May 10, 2024 18:07 ET
Terran Orbital Schedules Conference Call to Discuss First Quarter 2024 Financial Results
Terran Orbital Corporation (NYSE: LLAP) (“Terran Orbital” or the “Company”), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced it will host the Company’s first quarter 2024 earnings conference call at 11:00 a.m. E.T. on May 14, 2024....
May 10, 2024 18:06 ET
Best’s Commentary: Low Agribusiness Exposure to Help Brazil’s Reinsurers Weather Floods
Due to reduced exposures in volatile lines of business such as agribusiness, (re)insurance companies in Brazil should be able to weather any impacts from the recent widespread flooding in Rio Grande do Sul, according to an AM Best commentary....
May 10, 2024 17:30 ET
Vroom Announces First Quarter 2024 Results
Vroom, Inc. (Nasdaq:VRM) today announced financial results for the first quarter ended March 31, 2024....
May 10, 2024 17:01 ET
Sky Harbour to Report 2024 Q1 Results and Host Webcast Investor Call Tuesday, May 14, 2024
Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its First Quarter 2024 financial results after market close on Tuesday, May 14, 2024, and to host an investor webcast at 5:00 pm ET the same day. On the call, Sky Harbour will review quarterly financial results and provide a general business update. A question-and-answer session with Sky Harbour leadership will follow. Both the call and webcast are open ...
May 10, 2024 16:31 ET
HCA Healthcare, Inc. to Present at June Healthcare Conference
HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference:...
May 10, 2024 16:30 ET
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board...
May 10, 2024 16:30 ET
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a liquidating cash dividend in the amount of $15.10 per share. The dividend is expected to be paid on or about May 17, 2024. Merrimack’s Common Stock will trade on NASDAQ through May 17, 2024 and will delist from NASDAQ on May 20, 2024....
May 10, 2024 16:15 ET
GE Vernova Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
GE Vernova Inc. (NYSE: GEV) today announced that it received notice of an unsolicited “mini-tender” offer by TRC Capital Investment Corporation (TRC Capital) to purchase up to 1,000,000 shares of GE Vernova common stock, which represents approximately 0.4% of the shares outstanding, at a price of $155.00 per share in cash. TRC Capital’s offer price is 7.39% less than the $167.36 closing price per share of GE Vernova’s common stock on May 7, 2024, the last trading day before the mini-tender offer appears to have commenced....
May 10, 2024 16:05 ET
RLI Names Deb Millum as Vice President, Claim
RLI Corp. (NYSE: RLI) -- RLI Corp. announced today the promotion of Deb Millum to Vice President, Claim. In her new role, Millum will assume executive leadership and oversight responsibility for RLI’s Transportation, Non-Transportation Auto and Personal Umbrella product claims....
May 10, 2024 16:00 ET
HEI Reports First Quarter 2024 Results
“We continue to work in earnest with key stakeholders to help our community recover from the devastating impacts of the Maui wildfires. The State’s One ‘Ohana fund has seen steady uptake and the Governor recently extended the registration deadline, and mediation discussions are underway with those impacted by the fires. Hawaii’s legislative session recently concluded, and although we are disappointed that we ran out of time to pass legislation this session, our governor and legislature are highly engaged in determining how to design legislation that best makes sense for Hawaii, our customers a...